ÃÛÑ¿´«Ã½

The PROMIS Gastrointestinal Constipation Scale assesses the frequency and intensity of incomplete evacuation, rectal pain, straining, and hard stools, as well as the need for manual extraction of stool.

The Revised Fibromyalgia Impact Questionnaire (FIQR) is used to evaluate function, overall impact and symptoms of fibromyalgia over the past 7 days.

The Tampa Scale for Kinesiophobia (TSK) is a 12-item questionnaire that quantifies fear of movement or (re)injury.

The Clinical Global Impression of Change (CGIC) is a one-item measure that assesses the degree of change of a patient's condition.

The PROMIS Fatigue 4a assesses a range of self-reported fatigue symptoms.

The PROMIS Fatigue 13a assesses a range of self-reported fatigue symptoms.

The Cumulative Illness Rating Scale (CIRS) assesses physical impairment.

The Subjective Opiate Withdrawal Scale (SOWS) is self-administered rating scale to measure the signs and symptoms of opiate withdrawal.

The Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP-R) evaluates a patient's relative risk for developing problems when placed on long-term opioid therapy.

The Opioid Risk Tool (ORT) is a self-report screening tool for adult patients in primary care settings to assess risk for opioid abuse among individuals prescribed opioids for treatment of chronic pain.

The PROMIS Pediatric Global Health measure is a brief and reliable 7-item summary assessment of a child's self-reported health.

The Self-Administered Comorbidity Questionnaire (SCQ) assesses comorbid conditions in clinical and health services research.

The PROMIS PROPr 29+2 is a combination of PROMIS-29 Profile v2.1 and two items from PROMIS Cognitive Function Abilities v2.0.

The Mini-International Neuropsychiatric Interview Substance Use Disorder Scale was designed as a brief structured diagnostic interview for substance use disorders.

The Allodynia Symptom Checklist (ASC-12) assesses frequency of cutaneous allodynia symptoms during headache attacks.

The Treatment Evaluation Inventory Modified (TEI) assesses parents' acceptance of procedures for behavior problem children.

The Health Survey (SF-12v2) is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality of life measure.

The Migraine Disability Assessment (MIDAS) questionnaire assesses headache-related disability with the aim of improving migraine care.

The Clinical Opiate Withdrawal Scale (COWS) is a clinician-administered instrument that rates 11 common opiate withdrawal signs or symptoms.

The Current Opioid Misuse Measure (COMM) is a self-assessment to monitor chronic pain patients on opioid therapy.

The PROMIS 43 Profile is a collection of forty-three items drawn from the seven primary PROMIS domains (depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and satisfaction with participation in social roles).

The Orthostatic Hypotension Questionnaire (OHQ) assesses the burden of symptoms with two components: the six-item symptoms assessment scale and a four-item daily activity scale.

The EQ-5D-5L is a self-assessed, health related, quality of life questionnaire. The scale measures quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.

The Tobacco, Alcohol, Prescription medication, and other Substance Use 2 (TAPS 2) identifies specific substance(s) use and risk level, ranging in severity from problem use to the more severe substance use disorder.

The Timeline Follow Back (TLFB) is used as a clinical and research tool to obtain a variety of quantitative estimates of marijuana, cigarette, and other drug use over a 7-day period.